Lung Cancer: Blocking GH Receptor Boosts Treatment
A decades-old drug, initially developed to treat a rare hormonal disorder, is showing remarkable promise as a potential weapon against the most deadly form of lung cancer. Researchers at Ohio University have discovered that blocking the growth hormone receptor (GHR) can significantly enhance the effectiveness of chemotherapy in Non-Small Cell Lung Cancer (NSCLC), a disease … Read more